Through preliminary experiments, we established SPTBN2 as a potential oncogene, which was upregulated and correlated with poor prognosis in patients with NSCLC (Supplementary Figs. 1A–I). The gene discussed is SPTBN2; the disease is non-small cell lung carcinoma.